Copyright Reports & Markets. All rights reserved.

Global Tylvalosin Tartrate Soluble Powder Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Tylvalosin Tartrate Soluble Powder Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 500mg/g
    • 1.3.3 625mg/g
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Tylvalosin Tartrate Soluble Powder Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Mycoplasma Infection in Pigs
    • 1.4.3 Mycoplasma Infection in Chickens
    • 1.4.4 Others
  • 1.5 Global Tylvalosin Tartrate Soluble Powder Market Size & Forecast
    • 1.5.1 Global Tylvalosin Tartrate Soluble Powder Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Tylvalosin Tartrate Soluble Powder Sales Quantity (2020-2031)
    • 1.5.3 Global Tylvalosin Tartrate Soluble Powder Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Fujian Sunvet Bio-Technology
    • 2.1.1 Fujian Sunvet Bio-Technology Details
    • 2.1.2 Fujian Sunvet Bio-Technology Major Business
    • 2.1.3 Fujian Sunvet Bio-Technology Tylvalosin Tartrate Soluble Powder Product and Services
    • 2.1.4 Fujian Sunvet Bio-Technology Tylvalosin Tartrate Soluble Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Fujian Sunvet Bio-Technology Recent Developments/Updates
  • 2.2 Anbiolife
    • 2.2.1 Anbiolife Details
    • 2.2.2 Anbiolife Major Business
    • 2.2.3 Anbiolife Tylvalosin Tartrate Soluble Powder Product and Services
    • 2.2.4 Anbiolife Tylvalosin Tartrate Soluble Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Anbiolife Recent Developments/Updates
  • 2.3 Qilu Pharmaceutical
    • 2.3.1 Qilu Pharmaceutical Details
    • 2.3.2 Qilu Pharmaceutical Major Business
    • 2.3.3 Qilu Pharmaceutical Tylvalosin Tartrate Soluble Powder Product and Services
    • 2.3.4 Qilu Pharmaceutical Tylvalosin Tartrate Soluble Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.4 The United Animal Healthcare
    • 2.4.1 The United Animal Healthcare Details
    • 2.4.2 The United Animal Healthcare Major Business
    • 2.4.3 The United Animal Healthcare Tylvalosin Tartrate Soluble Powder Product and Services
    • 2.4.4 The United Animal Healthcare Tylvalosin Tartrate Soluble Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 The United Animal Healthcare Recent Developments/Updates
  • 2.5 Jizhong Shouyao
    • 2.5.1 Jizhong Shouyao Details
    • 2.5.2 Jizhong Shouyao Major Business
    • 2.5.3 Jizhong Shouyao Tylvalosin Tartrate Soluble Powder Product and Services
    • 2.5.4 Jizhong Shouyao Tylvalosin Tartrate Soluble Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Jizhong Shouyao Recent Developments/Updates
  • 2.6 Zhengzhou Fuyuan Animal Pharmaceutical
    • 2.6.1 Zhengzhou Fuyuan Animal Pharmaceutical Details
    • 2.6.2 Zhengzhou Fuyuan Animal Pharmaceutical Major Business
    • 2.6.3 Zhengzhou Fuyuan Animal Pharmaceutical Tylvalosin Tartrate Soluble Powder Product and Services
    • 2.6.4 Zhengzhou Fuyuan Animal Pharmaceutical Tylvalosin Tartrate Soluble Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Zhengzhou Fuyuan Animal Pharmaceutical Recent Developments/Updates
  • 2.7 Deruncin Animal Pharmaceutical
    • 2.7.1 Deruncin Animal Pharmaceutical Details
    • 2.7.2 Deruncin Animal Pharmaceutical Major Business
    • 2.7.3 Deruncin Animal Pharmaceutical Tylvalosin Tartrate Soluble Powder Product and Services
    • 2.7.4 Deruncin Animal Pharmaceutical Tylvalosin Tartrate Soluble Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Deruncin Animal Pharmaceutical Recent Developments/Updates
  • 2.8 Shandong Shengli Bioengineering
    • 2.8.1 Shandong Shengli Bioengineering Details
    • 2.8.2 Shandong Shengli Bioengineering Major Business
    • 2.8.3 Shandong Shengli Bioengineering Tylvalosin Tartrate Soluble Powder Product and Services
    • 2.8.4 Shandong Shengli Bioengineering Tylvalosin Tartrate Soluble Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Shandong Shengli Bioengineering Recent Developments/Updates
  • 2.9 Wuhan Huisheng Biotechnology
    • 2.9.1 Wuhan Huisheng Biotechnology Details
    • 2.9.2 Wuhan Huisheng Biotechnology Major Business
    • 2.9.3 Wuhan Huisheng Biotechnology Tylvalosin Tartrate Soluble Powder Product and Services
    • 2.9.4 Wuhan Huisheng Biotechnology Tylvalosin Tartrate Soluble Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Wuhan Huisheng Biotechnology Recent Developments/Updates
  • 2.10 Tianjin Nuva Animal Pharmaceutical
    • 2.10.1 Tianjin Nuva Animal Pharmaceutical Details
    • 2.10.2 Tianjin Nuva Animal Pharmaceutical Major Business
    • 2.10.3 Tianjin Nuva Animal Pharmaceutical Tylvalosin Tartrate Soluble Powder Product and Services
    • 2.10.4 Tianjin Nuva Animal Pharmaceutical Tylvalosin Tartrate Soluble Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Tianjin Nuva Animal Pharmaceutical Recent Developments/Updates
  • 2.11 Ringpu Biology
    • 2.11.1 Ringpu Biology Details
    • 2.11.2 Ringpu Biology Major Business
    • 2.11.3 Ringpu Biology Tylvalosin Tartrate Soluble Powder Product and Services
    • 2.11.4 Ringpu Biology Tylvalosin Tartrate Soluble Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Ringpu Biology Recent Developments/Updates
  • 2.12 Shandong Jinrui Biotechnolo
    • 2.12.1 Shandong Jinrui Biotechnolo Details
    • 2.12.2 Shandong Jinrui Biotechnolo Major Business
    • 2.12.3 Shandong Jinrui Biotechnolo Tylvalosin Tartrate Soluble Powder Product and Services
    • 2.12.4 Shandong Jinrui Biotechnolo Tylvalosin Tartrate Soluble Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Shandong Jinrui Biotechnolo Recent Developments/Updates
  • 2.13 Provet
    • 2.13.1 Provet Details
    • 2.13.2 Provet Major Business
    • 2.13.3 Provet Tylvalosin Tartrate Soluble Powder Product and Services
    • 2.13.4 Provet Tylvalosin Tartrate Soluble Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Provet Recent Developments/Updates
  • 2.14 AdvaCare Pharma
    • 2.14.1 AdvaCare Pharma Details
    • 2.14.2 AdvaCare Pharma Major Business
    • 2.14.3 AdvaCare Pharma Tylvalosin Tartrate Soluble Powder Product and Services
    • 2.14.4 AdvaCare Pharma Tylvalosin Tartrate Soluble Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 AdvaCare Pharma Recent Developments/Updates

3 Competitive Environment: Tylvalosin Tartrate Soluble Powder by Manufacturer

  • 3.1 Global Tylvalosin Tartrate Soluble Powder Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Tylvalosin Tartrate Soluble Powder Revenue by Manufacturer (2020-2025)
  • 3.3 Global Tylvalosin Tartrate Soluble Powder Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Tylvalosin Tartrate Soluble Powder by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Tylvalosin Tartrate Soluble Powder Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Tylvalosin Tartrate Soluble Powder Manufacturer Market Share in 2024
  • 3.5 Tylvalosin Tartrate Soluble Powder Market: Overall Company Footprint Analysis
    • 3.5.1 Tylvalosin Tartrate Soluble Powder Market: Region Footprint
    • 3.5.2 Tylvalosin Tartrate Soluble Powder Market: Company Product Type Footprint
    • 3.5.3 Tylvalosin Tartrate Soluble Powder Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Tylvalosin Tartrate Soluble Powder Market Size by Region
    • 4.1.1 Global Tylvalosin Tartrate Soluble Powder Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Tylvalosin Tartrate Soluble Powder Consumption Value by Region (2020-2031)
    • 4.1.3 Global Tylvalosin Tartrate Soluble Powder Average Price by Region (2020-2031)
  • 4.2 North America Tylvalosin Tartrate Soluble Powder Consumption Value (2020-2031)
  • 4.3 Europe Tylvalosin Tartrate Soluble Powder Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Tylvalosin Tartrate Soluble Powder Consumption Value (2020-2031)
  • 4.5 South America Tylvalosin Tartrate Soluble Powder Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Tylvalosin Tartrate Soluble Powder Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Tylvalosin Tartrate Soluble Powder Sales Quantity by Type (2020-2031)
  • 5.2 Global Tylvalosin Tartrate Soluble Powder Consumption Value by Type (2020-2031)
  • 5.3 Global Tylvalosin Tartrate Soluble Powder Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Tylvalosin Tartrate Soluble Powder Sales Quantity by Application (2020-2031)
  • 6.2 Global Tylvalosin Tartrate Soluble Powder Consumption Value by Application (2020-2031)
  • 6.3 Global Tylvalosin Tartrate Soluble Powder Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Tylvalosin Tartrate Soluble Powder Sales Quantity by Type (2020-2031)
  • 7.2 North America Tylvalosin Tartrate Soluble Powder Sales Quantity by Application (2020-2031)
  • 7.3 North America Tylvalosin Tartrate Soluble Powder Market Size by Country
    • 7.3.1 North America Tylvalosin Tartrate Soluble Powder Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Tylvalosin Tartrate Soluble Powder Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Tylvalosin Tartrate Soluble Powder Sales Quantity by Type (2020-2031)
  • 8.2 Europe Tylvalosin Tartrate Soluble Powder Sales Quantity by Application (2020-2031)
  • 8.3 Europe Tylvalosin Tartrate Soluble Powder Market Size by Country
    • 8.3.1 Europe Tylvalosin Tartrate Soluble Powder Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Tylvalosin Tartrate Soluble Powder Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Tylvalosin Tartrate Soluble Powder Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Tylvalosin Tartrate Soluble Powder Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Tylvalosin Tartrate Soluble Powder Market Size by Region
    • 9.3.1 Asia-Pacific Tylvalosin Tartrate Soluble Powder Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Tylvalosin Tartrate Soluble Powder Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Tylvalosin Tartrate Soluble Powder Sales Quantity by Type (2020-2031)
  • 10.2 South America Tylvalosin Tartrate Soluble Powder Sales Quantity by Application (2020-2031)
  • 10.3 South America Tylvalosin Tartrate Soluble Powder Market Size by Country
    • 10.3.1 South America Tylvalosin Tartrate Soluble Powder Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Tylvalosin Tartrate Soluble Powder Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Tylvalosin Tartrate Soluble Powder Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Tylvalosin Tartrate Soluble Powder Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Tylvalosin Tartrate Soluble Powder Market Size by Country
    • 11.3.1 Middle East & Africa Tylvalosin Tartrate Soluble Powder Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Tylvalosin Tartrate Soluble Powder Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Tylvalosin Tartrate Soluble Powder Market Drivers
  • 12.2 Tylvalosin Tartrate Soluble Powder Market Restraints
  • 12.3 Tylvalosin Tartrate Soluble Powder Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Tylvalosin Tartrate Soluble Powder and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Tylvalosin Tartrate Soluble Powder
  • 13.3 Tylvalosin Tartrate Soluble Powder Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Tylvalosin Tartrate Soluble Powder Typical Distributors
  • 14.3 Tylvalosin Tartrate Soluble Powder Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Tylvalosin Tartrate Soluble Powder market size was valued at US$ 2544 million in 2024 and is forecast to a readjusted size of USD 3487 million by 2031 with a CAGR of 5.4% during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Tylvalosin Tartrate Soluble Powder is a veterinary antibiotic formulation containing tylvalosin (acetyl-isovaleryl-tylosin) as the active ingredient, with tartrate salt enhancing solubility. As a third-generation macrolide, tylvalosin exhibits superior activity against mycoplasma (e.g., *Mycoplasma gallisepticum*, *M. hyopneumoniae*) and Gram-positive bacteria (e.g., *Streptococcus*), making it ideal for treating chronic respiratory disease (CRD), infectious rhinitis, and arthritis in poultry and swine. The soluble powder formulation allows convenient administration via drinking water, ensuring high herd-level absorption with minimal palatability issues. Its use in livestock production emphasizes precise dosing and adherence to withdrawal periods to mitigate antimicrobial resistance risks.
    This report is a detailed and comprehensive analysis for global Tylvalosin Tartrate Soluble Powder market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Tylvalosin Tartrate Soluble Powder market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
    Global Tylvalosin Tartrate Soluble Powder market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
    Global Tylvalosin Tartrate Soluble Powder market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
    Global Tylvalosin Tartrate Soluble Powder market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Tylvalosin Tartrate Soluble Powder
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Tylvalosin Tartrate Soluble Powder market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fujian Sunvet Bio-Technology, Anbiolife, Qilu Pharmaceutical, The United Animal Healthcare, Jizhong Shouyao, Zhengzhou Fuyuan Animal Pharmaceutical, Deruncin Animal Pharmaceutical, Shandong Shengli Bioengineering, Wuhan Huisheng Biotechnology, Tianjin Nuva Animal Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Tylvalosin Tartrate Soluble Powder market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    500mg/g
    625mg/g
    Others
    Market segment by Application
    Mycoplasma Infection in Pigs
    Mycoplasma Infection in Chickens
    Others
    Major players covered
    Fujian Sunvet Bio-Technology
    Anbiolife
    Qilu Pharmaceutical
    The United Animal Healthcare
    Jizhong Shouyao
    Zhengzhou Fuyuan Animal Pharmaceutical
    Deruncin Animal Pharmaceutical
    Shandong Shengli Bioengineering
    Wuhan Huisheng Biotechnology
    Tianjin Nuva Animal Pharmaceutical
    Ringpu Biology
    Shandong Jinrui Biotechnolo
    Provet
    AdvaCare Pharma
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Tylvalosin Tartrate Soluble Powder product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Tylvalosin Tartrate Soluble Powder, with price, sales quantity, revenue, and global market share of Tylvalosin Tartrate Soluble Powder from 2020 to 2025.
    Chapter 3, the Tylvalosin Tartrate Soluble Powder competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Tylvalosin Tartrate Soluble Powder breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Tylvalosin Tartrate Soluble Powder market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Tylvalosin Tartrate Soluble Powder.
    Chapter 14 and 15, to describe Tylvalosin Tartrate Soluble Powder sales channel, distributors, customers, research findings and conclusion.

    Buy now